iX Biopharma Ltd. (SGX:42C)
Singapore · Delayed Price · Currency is SGD 0.3300
-0.0150 (-4.35%)
Jun 10, 2026, 5:09 PM SGT
iX Biopharma Cash Flow Statement
Financials in millions SGD. Fiscal year is July - June.
Millions SGD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Net Income | -4.67 | -10.14 | -10.79 | -9.62 | -4.6 | -8.23 |
Depreciation & Amortization | 0.73 | 0.85 | 0.86 | 0.89 | 1.01 | 1 |
Other Amortization | 0 | 0 | 0.01 | 0.04 | 0.05 | 0.05 |
Loss (Gain) From Sale of Assets | - | - | - | - | - | -0 |
Loss (Gain) From Sale of Investments | - | 0.01 | 2.51 | -1.74 | 3.26 | - |
Stock-Based Compensation | 0 | 0.03 | -0.85 | 0.86 | 1.38 | 1 |
Provision & Write-off of Bad Debts | 0.03 | - | 0.11 | - | - | - |
Other Operating Activities | -0.99 | 4.57 | 1.46 | 2.36 | 2.72 | -1.84 |
Change in Accounts Receivable | -0.08 | 0.08 | -0.11 | -0.85 | -0.23 | 0.02 |
Change in Inventory | -0.05 | 0.31 | -0.62 | -0.2 | -0.04 | -0.35 |
Change in Accounts Payable | -0.55 | 0.48 | 0.86 | 0.71 | -0.27 | -0.07 |
Change in Other Net Operating Assets | -0.16 | 0.06 | 0 | -0.12 | -0.16 | 0.07 |
Operating Cash Flow | -5.72 | -3.76 | -6.55 | -7.66 | 3.12 | -8.35 |
Capital Expenditures | -0.07 | -0.2 | -0.27 | -0.7 | -0.2 | -0.55 |
Sale of Property, Plant & Equipment | - | - | 1.34 | - | - | 0.05 |
Sale (Purchase) of Intangibles | - | - | -0.01 | - | - | - |
Investment in Securities | - | - | - | - | -5.42 | - |
Investing Cash Flow | -0.07 | -0.2 | 1.06 | -0.7 | -5.62 | -0.51 |
Long-Term Debt Issued | - | 1.51 | 2.03 | - | 1.4 | - |
Long-Term Debt Repaid | - | -1.05 | -1.02 | -0.99 | -1.02 | -0.6 |
Net Debt Issued (Repaid) | 0.2 | 0.46 | 1.01 | -0.99 | 0.37 | -0.6 |
Issuance of Common Stock | 21.72 | 3.25 | - | 2.73 | 9.62 | 10.18 |
Other Financing Activities | -0.75 | -0.59 | -0.29 | -0.31 | -0.2 | 0.45 |
Financing Cash Flow | 21.17 | 3.12 | 0.72 | 1.42 | 9.79 | 10.02 |
Foreign Exchange Rate Adjustments | -0.02 | 0.01 | - | -0.05 | 0.03 | -0.05 |
Net Cash Flow | 15.35 | -0.83 | -4.77 | -6.98 | 7.32 | 1.12 |
Free Cash Flow | -5.8 | -3.96 | -6.83 | -8.36 | 2.92 | -8.91 |
Free Cash Flow Margin | -82.80% | -50.97% | -114.57% | -141.30% | 20.31% | -510.32% |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 | -0.01 |
Cash Interest Paid | 0.68 | 0.68 | 0.32 | 0.27 | 0.2 | 0.17 |
Cash Income Tax Paid | - | -0.73 | -0.48 | -0.54 | -0.71 | -0.72 |
Levered Free Cash Flow | -3.98 | -1.86 | -5 | -6.58 | 3.76 | -6.46 |
Unlevered Free Cash Flow | -3.56 | -1.66 | -4.72 | -6.41 | 3.89 | -6.36 |
Change in Working Capital | -0.84 | 0.93 | 0.14 | -0.45 | -0.7 | -0.33 |